

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting⦠read more
Healthcare
Drug ManufacturersāSpecialty & Generic
5 years
USD
Exclusive to Premium users
$0.70
Price+8.74%
$0.06
$1.405m
Small
0x
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$0.00
-
1y CAGR-33.3%
3y CAGR-25.0%
5y CAGR-$4.086m
+72.0%
1y CAGR+3.2%
3y CAGR-2.9%
5y CAGR-$2.30
+92.9%
1y CAGR+62.5%
3y CAGR+44.0%
5y CAGR$8.443m
$11.162m
Assets$2.719m
Liabilities$56k
Debt0.5%
-
Debt to EBITDA-$5.960m
+52.8%
1y CAGR-13.2%
3y CAGR-9.4%
5y CAGR